Victory RS Science and Technology C holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Victory RS Science and Technology Fund Class C RINCX
- NAV / 1-Day Return $23.08 / +0.57 %
- Fund Size $236.1M
- Adjusted Expense Ratio 2.280%
- Net Expense Ratio 2.280%
- Fee Level: Distribution Above Average
- Share Class Type Level Load
- Morningstar Category Technology
- Equity Style Box (Funds) Large Growth
- Minimum Initial Investment $2,500
- Investment Status Open
- TTM Yield 0.00%
- Turnover Ratio 29%
Morningstar’s Analysis RINCX
Will RINCX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 42.8
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
NVIDIA Corp | 9.93 | 25M | Technology |
Microsoft Corp | 6.93 | 18M | Technology |
Meta Platforms Inc Class A | 4.98 | 13M | Communication Services |
Guardant Health Inc | 4.04 | 10M | Healthcare |
Amazon.com Inc | 3.36 | 9M | Consumer Cyclical |
Revolution Medicines Inc Ordinary Shares | 3.18 | 8M | Healthcare |
Semtech Corp | 3.00 | 8M | Technology |
Monolithic Power Systems Inc | 2.71 | 7M | Technology |
Arista Networks Inc | 2.37 | 6M | Technology |
Twist Bioscience Corp | 2.25 | 6M | Healthcare |